MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival
Abstract
Extramural venous invasion at baseline MRI was associated with worse survival in patients with locally advanced rectal cancer.
Purpose
To study the relationship between MRI-defined extramural venous invasion (EMVI) prior to treatment and prognosis in patients with locally advanced rectal cancer treated with neoadjuvant chemotherapy–radiation therapy followed by surgery.
Materials and Methods
This retrospective study included 517 patients with locally advanced rectal cancer evaluated from August 2008 to December 2014. Baseline and posttherapy MRI and follow-up data were retrieved for all patients. After training by using 328 cases with pathologic evaluation of EMVI after therapy, radiologists evaluated baseline MRI for EMVI status in addition to tumor size and characteristics, nodal status, and invasion of the mesorectal fascia. Reader reproducibility was determined by using κ coefficient. Kaplan-Meier curves and adjusted Cox models were used to determine the relationship of baseline MRI parameters to overall survival, metastasis-free survival, and local relapse-free survival.
Results
Among 517 patients, 335 (64.8%) were men; the mean age was 55.6 years ± 11.5 (standard deviation). At baseline, radiologists identified 259 of 517 (50%) patients with EMVI by using MRI. In adjusted analysis, EMVI and mesorectal fascial invasion at baseline MRI were predictors of metastasis-free survival (hazard ratio, 0.3 and 0.6; P ˂ .01 and P ˂ .02, respectively) and overall survival (hazard ratio, 0.5 and 0.5; P = .01 and P = .02, respectively). EMVI was the only factor associated with local relapse-free survival (hazard ratio, 0.3; P ˂ .01). The κ coefficient for determination of EMVI was 0.80.
Conclusion
Extramural venous invasion (EMVI) can be reliably evaluated with MRI. The presence of EMVI was associated with greater risk of local and distant tumor recurrence and overall death in patients with locally advanced rectal cancer treated with neoadjuvant chemotherapy–radiation therapy.
© RSNA, 2018
References
- 1. . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638–646.
- 2. . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12(6):575–582.
- 3. . Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991;34(9):798–804.
- 4. . A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann Surg 1988;208(3):379–389.
- 5. . Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 1984;2(8405):733–736.
- 6. . Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008;95(2):229–236.
- 7. . Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333(7572):779.
- 8. . The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg 2015;261(3):473–479.
- 9. . Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 2014;110(1):19–25.
- 10. . Pelvic MRI for guiding treatment decisions in rectal cancer. Oncology (Williston Park) 2014;28(8):667–677.
- 11. ; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi81–vi88.
- 12. . MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 2008;191(5):1517–1522.
- 13. . The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology 2013;268(2):330–344.
- 14. . MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 2015;25(5):1347–1355.
- 15. . Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer. Dis Colon Rectum 2015;58(2):186–192.
- 16. . Acute toxicity and tumor response in locally advanced rectal cancer after preoperative chemoradiation therapy with shortening of the overall treatment time using intensity-modulated radiation therapy with simultaneous integrated boost: a phase 2 trial. Int J Radiat Oncol Biol Phys 2016;96(5):1003–1010.
- 17. . TNM Classification of Malignant Tumours. 7th ed. Weinheim, Germany: Wiley, 2010.
- 18. . MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 2011;18(12):3278–3284.
- 19. . Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011;253(4):711–719.
- 20. . The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma. Clin Radiol 2014;69(6):619–623.
Article History
Received: Dec 10 2017Revision requested: Jan 12 2018
Revision received: June 20 2018
Accepted: July 2 2018
Published online: Aug 28 2018
Published in print: Dec 2018